DE3673693D1 - Pyridinderivate und verfahren zu ihrer herstellung. - Google Patents

Pyridinderivate und verfahren zu ihrer herstellung.

Info

Publication number
DE3673693D1
DE3673693D1 DE8686106358T DE3673693T DE3673693D1 DE 3673693 D1 DE3673693 D1 DE 3673693D1 DE 8686106358 T DE8686106358 T DE 8686106358T DE 3673693 T DE3673693 T DE 3673693T DE 3673693 D1 DE3673693 D1 DE 3673693D1
Authority
DE
Germany
Prior art keywords
sub
lower alkyl
compound
hydrogen atom
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686106358T
Other languages
English (en)
Inventor
Takashi Mori
Nobuhiro Ohi
Yoshiyuki Ohsugi
Yasuhiro Yamashita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3673693D1 publication Critical patent/DE3673693D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DE8686106358T 1985-05-23 1986-05-09 Pyridinderivate und verfahren zu ihrer herstellung. Expired - Fee Related DE3673693D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11064285 1985-05-23

Publications (1)

Publication Number Publication Date
DE3673693D1 true DE3673693D1 (de) 1990-10-04

Family

ID=14540880

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686106358T Expired - Fee Related DE3673693D1 (de) 1985-05-23 1986-05-09 Pyridinderivate und verfahren zu ihrer herstellung.

Country Status (14)

Country Link
US (1) US4691018A (de)
EP (1) EP0203435B1 (de)
JP (1) JPS6253966A (de)
KR (1) KR860008980A (de)
CN (1) CN86103501A (de)
AT (1) ATE55992T1 (de)
AU (1) AU587251B2 (de)
CA (1) CA1240332A (de)
DE (1) DE3673693D1 (de)
ES (1) ES8707934A1 (de)
HU (1) HU195486B (de)
SU (1) SU1419517A3 (de)
YU (1) YU83686A (de)
ZA (1) ZA863706B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877795A (en) * 1987-01-30 1989-10-31 Kissei Pharmaceutical Co., Ltd. 4H-quinolizin-4-one compounds useful for the treatment of allergic bronchial asthma, allergic rhinitis atropic dermatitis and the like
DE3703963A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen
US4904657A (en) * 1987-09-24 1990-02-27 Kissei Pharmaceutical Co., Ltd. 4H-quinolizin-4-one compounds exhibiting therapeutic activities
JP2746832B2 (ja) * 1993-05-14 1998-05-06 大鵬薬品工業株式会社 眼局所抗アレルギー剤
TW264385B (de) * 1993-05-14 1995-12-01 Taiho Pharmaceutical Co Ltd
WO2010141883A1 (en) * 2009-06-04 2010-12-09 The Regents Of The University Of Colorado Compounds that modulate autoimmunity and methods of using the same
WO2012162697A1 (en) 2011-05-26 2012-11-29 The Regents Of The University Of Colorado, A Body Corporate Compounds that modulate autoimmunity and methods of using the same
US10568435B2 (en) 2012-08-30 2020-02-25 Huntleigh Technology Limited Multi-layered patient support cover system
WO2016115253A1 (en) 2015-01-14 2016-07-21 The Regents Of The University Ofcolordo, A Body Corporate Insulin mimotopes and methods of using the same
EP3432877B1 (de) 2016-03-24 2023-01-11 ImmunoMolecular Therapeutics, Inc. D-alpha-methyldopa zur behandlung von autoimmunerkrankungen
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3174885D1 (en) * 1981-02-03 1986-07-31 Ici Plc Process for the extraction of metal values and novel metal extractants
JPS58105920A (ja) * 1981-12-17 1983-06-24 Chugai Pharmaceut Co Ltd 抗癌剤
JPS58159465A (ja) * 1982-03-17 1983-09-21 Chugai Pharmaceut Co Ltd ピリジン誘導体

Also Published As

Publication number Publication date
ES555240A0 (es) 1987-09-01
JPH0225906B2 (de) 1990-06-06
EP0203435B1 (de) 1990-08-29
ATE55992T1 (de) 1990-09-15
CN86103501A (zh) 1987-01-21
US4691018A (en) 1987-09-01
ES8707934A1 (es) 1987-09-01
EP0203435A3 (en) 1988-01-07
AU5726786A (en) 1986-11-27
SU1419517A3 (ru) 1988-08-23
ZA863706B (en) 1987-01-28
CA1240332A (en) 1988-08-09
EP0203435A2 (de) 1986-12-03
HU195486B (en) 1988-05-30
AU587251B2 (en) 1989-08-10
YU83686A (en) 1988-06-30
JPS6253966A (ja) 1987-03-09
KR860008980A (ko) 1986-12-19
HUT41735A (en) 1987-05-28

Similar Documents

Publication Publication Date Title
ATE150462T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung
NO934501L (no) Karboksylsyrederivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling
NO943093L (no) Fremgangsmåte for fremstilling av clavulansyre
DE3673693D1 (de) Pyridinderivate und verfahren zu ihrer herstellung.
ATE36699T1 (de) Chinonderivate, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung.
DE3680800D1 (de) Verfahren zur herstellung von (6r)-tetrahydro-l-biopterin.
ATE131173T1 (de) Fluorierte gallensäure-derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen daraus.
DE3675087D1 (de) Pyridoncarbonsauere-derivate und verfahren zu ihrer herstellung.
ATE36859T1 (de) 4'-demethyl-4-epipodophyllotoxin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3870801D1 (de) Gallensaeure-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die sie enthalten.
AT379800B (de) Verfahren zur herstellung von neuen 2-oxazetidin-derivaten
ATE124953T1 (de) Gallensäure-derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen daraus.
EP0132764A3 (en) New compounds derived from diphenyl-methylene-ethylamine
DE3785878D1 (de) 3,4-disubstituierte-2-azetidinon-derivate und verfahren zu ihrer herstellung.
ES8603184A1 (es) Metodo de preparar un derivado de acido b-carbolin-3-carbo- xilico
DE3867281D1 (de) Calcium-4,6-dioxo-4h-pyrano(3,2-g)-chinolin-2,8-dicarboxylat-derivat, verfahren zu seiner herstellung und dieses enthaltende zusammensetzungen.
ES8701738A1 (es) Procedimiento para preparar nuevos 1,2,4-triazolo-carbamatos
ATE21101T1 (de) N-iminopyridinium-betain-derivate, ihre herstellung und ihre verwendung als arzneimittel.
DE3480839D1 (de) Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung.
AU655869B2 (en) An amphoteric tricyclic compound
ATE107631T1 (de) Verfahren zur herstellung von indolinon-2- derivaten.
EP0367671A3 (de) Beta-D-phenylthioxyloside, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ES8707537A1 (es) Un metodo para preparar derivados de acido 2-amino-5-oxo-5h-1 benzopirano 2,3-b piridin-3-carboxilico
ATE156824T1 (de) Verfahren zur herstellung von pyrido(1,2- a>pyrimidinderivaten
FR2583756B1 (fr) Procede de preparation des derives de la 2-halo-nicergoline et leurs sels d'addition avec des acides ainsi que des 2-halonicergolines nouvelles, compositions comportant des 2-halonicergolines et procede de preparation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee